Blood filter shows promise for preeclampsia control in small trial
NCT ID NCT02923206
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 28 times
Summary
This study tested a medical device that filters a harmful protein called sFlt-1 from the blood of pregnant women with preeclampsia, a serious condition causing high blood pressure. The goal was to see if the treatment is safe and can help control the disease. The trial included 21 participants and focused on safety for both mother and baby.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cambridge Clinical Trials Unit, Addenbrooke's Hospital
Cambridge, CB2 0QQ, United Kingdom
-
Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital
Oxford, OX3 9DU, United Kingdom
-
Universitätsklinikum Köln
Cologne, 50937, Germany
-
Universitätsklinikum Leipzig
Leipzig, 04103, Germany
Conditions
Explore the condition pages connected to this study.